Henric Bjorn Bjarke Inozyme Pharma, Inc. (INZY) insider trading activity

INZY Quotes by TradingView

Henric Bjorn Bjarke is SVP, COO of Inozyme Pharma, Inc.. Currently has a direct ownership of 105,441 shares of INZY, which is worth approximately $317,377. The most recent transaction as insider was on Dec 15, 2022, when has been sold 21,500 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $29,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
0% 12M change
Total Value Held $317,377

Henric Bjorn Bjarke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2022
BUY
Open market or private purchase
$29,884 $1.39 p/Share
21,500 Added 16.94%
105,441 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
$7,558 $2.28 p/Share
3,315 Added 3.8%
83,941 Common Stock
Apr 19 2022
BUY
Open market or private purchase
$99,999 $3.69 p/Share
27,100 Added 25.16%
80,626 Common Stock
HBB

Henric Bjorn Bjarke

SVP, COO
Boston, MA

Track Institutional and Insider Activities on INZY

Follow Inozyme Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

News

Receive news related to Inozyme Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INZY